Events

Press contacts

Helpdesks will operate at the EMCDDA (Lisbon) on the day of the launch to answer journalists’ questions.

Before 15 November (for details on the launch, scheduling interviews, etc), please ask for the press office at the following numbers:

Tel. ++ 351 211 21 02 00 (general)
Tel. ++ 351 211 21 02 40 (Maria José Louro)

From 15 November onwards, Annual report-related calls will be dispatched according to questions and requests for interviews, please contact the following number:

Tel. ++ 351 211 21 02 25 (Liesbeth Vandam)

Helpdesks at the Reitox focal points will answer country-specific queries.

15.11.2011: Annual report 2011 launch

• Launch date: Tuesday, 15 November 2011
• Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time)
• Venue: Conference Centre, Cais do Sodré, Lisbon

The EU drugs agency will present its annual assessment of Europe’s drugs problem in its Annual report 2011 to be released on 15 November in Lisbon. The report, the agency’s flagship publication, provides the latest data and commentary on the drug situation across the 27 EU Member States, Croatia, Turkey and Norway. Key challenges are discussed along with some of the promising practices used to address drug problems today. Where possible, European data are placed in a global context.

Download the report and related documents

• Annual report (PDF, available in 22 languages)
  
• Selected issues 2011: Cost and financing of drug treatment services in Europe (PDF, available in English)
• Selected issues 2011: Mortality related to drug use: public health implications (PDF, available in English)
• Selected issues 2011: Guidelines for the treatment of drug dependence: a European perspective (PDF, available in English)
• Country overviews (online product, available in English)
• National reports 2010 (PDF, available in English)

News material

• 10.10.2011, announcement: 'Annual report 2011: the state of the drugs problem in Europe — EU drugs agency presents the latest statistics, trends and analysis' (News release No 4/2011, Word or pdf, available in 22 languages)
• News release No 7/2011, Word or pdf, available in 22 languages
• News release No 8/2011, Word or pdf, available in 22 languages
• European Commission press release: Drugs report: Commissioner Malmström calls for vigilance on synthetic drugs and asks more anti-trafficking efforts
• Drugnet Europe 76 newsletter (pdf, available in English)
• Speeches at the press conference
• Audio (MP3) of press conference
• Video extracts from press conference

Related documents

• Online sales of new psychoactive substances/'legal highs': summary of results from the 2011 multilingual snapshots (pdf, available in English)
• Summary report from EMCDDA Trendspotter meeting 18–19 October 2011 (pdf, available in English)
  
• HIV/AIDS among IDUs in Greece: report of a recent outbreak and initial response policies
• Update — risk of HIV outbreaks among drug injectors in the EU

 

 

Related publications

• 2011 Annual report on the state of the drugs problem in Europe November 2011

  The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon.

• Mortality November 2011

  This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented.

• Cost and financing of drug treatment services November 2011

  This Selected issue provides an exploratory European overview of costs associated with treatment for drug dependence. The cost of drug treatment in Europe is looked at from two main angles in this report.

• Drugnet Europe 76 November 2011

  Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership.

• Guidelines for the treatment of drug dependence November 2011

  This report focuses on the topic of improving treatment quality by the development of guidelines.

• Online sales of new psychoactive substances / 'legal highs' November 2011

  This paper presents findings from the two most recent rapid assessments of the online availability of substances.

All publications >>